The Rise of the Emerging Markets

The role of emerging markets in the pharmaceutical industry is more relevant now than ever. Markets such as India and China represent significant opportunities for growth because of their rapid economic expansion. Annual pharmaceutical sales in the emerging markets is expected to reach $400b by 2020, equivalent to current sales in the US and top five European markets combined.

With the globalization of the industry, manufacturers are increasingly outsourcing and off shoring numerous functions to the emerging markets.

Emerging Markets Consulting (EMC) at PharmARC

PharmARC's dedicated EMC team enables you to address the growing demands of the emerging markets. We provide clients analyzed information and strategic inputs that will drive business in the emerging markets. Our faster project execution enables companies to respond proactively to customers, adapt to changing business demands, and thrive in the dynamic emerging market environment.

Being headquartered in an emerging market, we have experience in working across most therapeutic and functional areas. We have a strong information network of KOLs, distributors, primary market research agencies and key associations. Vast experience of over 5000 interviews with KOLs is testimony to our primary market research experience. We have a large amount of 'Ready Reckoner' databases across most therapeutic areas that considerably minimizes project timelines. Our expertise in accessing and analyzing various data sources in key 'data challenge' areas such as epidemiology and regulatory environments helps clients to successfully meet the challenges in emerging markets.

Key Service Offerings

1. Opportunity Assessment Across Key Therapeutic Areas
Opportunity Assessment across Key Therapeutic Areas Epidemiology, Diagnosis and Treatment, Economic burden and Cost benefit analysis, Market-size estimation, Pipeline analysis, Unmet needs assessment and Gap analysis.

2. Identification and Assessment of In-licensing/Partnering Opportunities in Emerging Markets
Our in-licensing expertise facilitates evaluating needs and identifying potential candidates. We help in deal-structuring and negotiations. PharmARC's comprehensive methodology helps clients in critical decision making during the in-licensing process.

3. Forecasting Support
EMC provides robust forecasts for pipeline and marketed products in the form of user-friendly, dynamic VBA programmed tools. PharmARC follows a 3-dimensional forecasting approach using Patient-based, Market-based, and Hybrid models.

The hybrid forecasting model is more suited for Emerging Markets as it will forecast the two critical areas, such as Indication level treated patient pool and Product level patient pool with PMR as one of the key components.

Strategic Product Support
International Brand Tracking (IBT): A key feature of EMC's IBT support is doing a product performance analysis as compared to the market.

IBT is designed as a dynamic tool to identify the KPIs that help in monitoring the sales performance across country affiliates of emerging markets. MS-Excel, VBA/web-based applications are used.

Price-Volume Analysis
A technique that examines change in sales volume in response to change in price. This analysis builds a relationship between price and volume or market share for a particular market segment.

Key Opinion Leader (KOL) Identification and Management Support
Accurate identification and validation of true KOLs
KOL segmentation and activity planning at regional and country levels

Sales Force Diagnostics: Analyzing Rep Behavior and Rep Quality
PharmARC undertakes Rep behavior and Rep Quality surveys to assess the effectiveness and thereby benchmark the performance of the client's reps against the competitor's.

Primary Market Research (PMR)
PharmARC provides PMR support through all stages of the product lifecycle. PharmARC has a network of KOLs/physicians spread across the globe. The uniqueness lies in our peer-to--peer interview approach. The majority of the interviews/discussions with KOLs/physicians are done by the physicians at PharmARC.

Functional Expertise
EMC has a dedicated team of experienced consultants who have worked in varied roles such as Brand Manager, Business Manager, Marketing Manager, Research analyst among others in the Indian pharmaceutical industry.

The team has successfully executed projects for 12 of the world's Top 15 pharmaceutical companies.

Project Experience in the Emerging Markets
India Market Entry Strategy for a Top 15 global pharmaceutical company
Evaluating in-licensing opportunities in the emerging markets for a leading pharmaceutical     company
Strategic business model development for conducting clinical research activities in India for a Top 5     global pharmaceutical company